Loading...
In patients with uncontrolled hypertension, interventional antihypertensive approaches have targeted baroreflex activation and renal sympathetic denervation. Now, researchers have tested an investigational, minimally invasive device to create a central iliac arteriovenous fistula, thereby lowering blood pressure through mitigation of arterial stiffness, a mechanism unaffected by sympathomodulation.
In this industry-sponsored, open-label, multicenter, randomized trial, 83 hypertensive patients (baseline office systolic blood pressure, ≥140 mm Hg; average daytime ambulatory blood pressure, ≥135 mm Hg systolic and ≥85 mm Hg diastolic) were randomly assigned to undergo percutaneous implantation of the device plus current treatment or to continue…